Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Dec 15;4(4):157-63.
doi: 10.1186/1710-1492-4-4-157. Epub 2008 Dec 15.

Patterns of Expression of Vaginal T-Cell Activation Markers during Estrogen-Maintained Vaginal Candidiasis

Affiliations

Patterns of Expression of Vaginal T-Cell Activation Markers during Estrogen-Maintained Vaginal Candidiasis

Ameera Al-Sadeq et al. Allergy Asthma Clin Immunol. .

Abstract

: The immunosuppressive activity of estrogen was further investigated by assessing the pattern of expression of CD25, CD28, CD69, and CD152 on vaginal T cells during estrogen-maintained vaginal candidiasis. A precipitous and significant decrease in vaginal fungal burden toward the end of week 3 postinfection was concurrent with a significant increase in vaginal lymphocyte numbers. During this period, the percentage of CD3+, CD3+CD4+, CD152+, and CD28+ vaginal T cells gradually and significantly increased. The percentage of CD3+ and CD3+CD4+ cells increased from 43% and 15% at day 0 to 77% and 40% at day 28 postinfection. Compared with 29% CD152+ vaginal T cells in naive mice, > 70% of vaginal T cells were CD152+ at day 28 postinfection. In conclusion, estrogen-maintained vaginal candidiasis results in postinfection time-dependent changes in the pattern of expression of CD152, CD28, and other T-cell markers, suggesting that T cells are subject to mixed suppression and activation signals.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Vaginal and splenic fungal burdens were evaluated in phosphate-buffered saline-treated control mice, estrogen-treated Candida albicans-infected experimental mice, and untreated C. albicans-infected control mice at days 7, 14, 21, 28, and 35 postinfection. The data shown represent mean CFU/tissue ± SD as calculated from three separate experiments using five to six mice/time point/experiment.
Figure 2
Figure 2
Absolute numbers of vaginal (A) and splenic (B) lymphocytes isolated from phosphate-buffered saline-treated control mice and estrogen-treated Candida albicans-infected experimental mice at days 7, 14, 21, 28, and 35 postinfection. Cell counts were plotted against the time points at which cells were harvested. The mean number of lymphocytes/tissue ± SEM was calculated based on data from three separate experiments, five to six mice/time point/experiment.
Figure 3
Figure 3
Vaginal lymphocytes isolated from phosphate-buffered saline-treated control mice and from estrogen-treated Candida albicans-infected experimental mice at day 28 postinfection were separately pooled from five to six mice and stained with anti-CD3 and anti-CD4 for two-colour flow cytometric (FCM) analysis or with anti-CD28, or anti-CD69 or anti-CD152 for single-colour FCM analysis. The data shown are representative of three separate experiments
Figure 4
Figure 4
Summary of the mean percentage expression ± SD of CD25, CD28, CD69, and CD152 on (A) vaginal and (B) splenic T cells isolated from estrogen-treated Candida albicans-infected experimental mice at days 0, 7, 14, 21, 28, and 35 postinfection. Means ± SD were calculated based on three separate experiments; at each time point, tissue lymphocytes were isolated from five to six mice and pooled prior to staining and flow cytometric analysis.

Similar articles

Cited by

References

    1. Ferrer J. Vaginal candidiasis: epidemiological and etiological factors. Int J Gynecol Obstet. 2000;71:521–7. doi: 10.1016/S0020-7292(00)00350-7. - DOI - PubMed
    1. Enoch DA, Ludlam HA, Brown NM. Invasive fungal infections: a review of epidemiology and management options. J Med Microbiol. 2006;55:809–18. doi: 10.1099/jmm.0.46548-0. - DOI - PubMed
    1. De Pauw BE. Increasing fungal infections in the intensive care unit. Surg Infect (Larchmt) 2006;7(Suppl 2):S93–6. - PubMed
    1. Abu-Elteen KH, Abdul-Malek AMM, Abdul-Wahid NA. Prevalence and susceptibility of vaginal yeast isolates in Jordan. Mycoses. 1997;40:179–85. doi: 10.1111/j.1439-0507.1997.tb00211.x. - DOI - PubMed
    1. Abu-Elteen KH. Increased incidence of vulvovaginal candidiasis caused by Candida glabrata in Jordan. Jpn J Infect Dis. 2001;54:103–7. - PubMed